{"nct_id":"NCT03104374","title":"A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2017-05-01","start_date_type":"ACTUAL","primary_completion_date":"2019-07-23","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}